Carregant...
Antibody response to cancer/testis (CT) antigens: A prognostic marker in cancer patients
Immune responses to tumor antigens have been reported in cancer patients. However, the relevance of such spontaneous immune responses to the clinical course has not been studied extensively. We showed that the overall survival of patients with antibodies against NY-ESO-1 or XAGE1 (GAGED2a) antigen w...
Guardat en:
| Publicat a: | Oncoimmunology |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4292217/ https://ncbi.nlm.nih.gov/pubmed/25941600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21624011.2014.970032 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|